Results 121 to 130 of about 13,609,159 (181)

Myo-Inositol and D-Chiro-Inositol Reduce DHT-Stimulated Changes in the Steroidogenic Activity of Adult Granulosa Cell Tumors. [PDF]

Int J Mol Sci
Wojciechowska AM, Zając P, Gogola-Mruk J, Kowalik MK, Ptak A.   +4 more
europepmc   +1 more source

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. [PDF]

J Clin Med, 2020
Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R.   +4 more
europepmc   +1 more source

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. [PDF]

Int J Mol Sci, 2020
Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo JL, Navarro JA, Vera K, Sanjuan C, Baixeras E, de Fonseca FR, Gutierrez-Adan A.   +9 more
europepmc   +1 more source

Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome. [PDF]

Nutrients
Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, Soresi M, Veronese N, Barbagallo M, Giannitrapani L.   +8 more
europepmc   +1 more source

Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports. [PDF]

Clin Med Insights Case Rep
Armijo-Sánchez A, Benítez Castillo N, García-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G, Torres Pellens V.   +6 more
europepmc   +1 more source

D-Chiro-Inositol's action as aromatase inhibitor: rationale and potential clinical targets.

European review for medical and pharmacological sciences, 2019
Laganà AS, Unfer V
openaire   +3 more sources

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. [PDF]

J Ovarian Res, 2019
Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M.   +10 more
europepmc   +1 more source

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. [PDF]

Cochrane Database Syst Rev, 2017
Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH.   +4 more
europepmc   +1 more source

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.

Gynecol Obstet Invest
Pustotina O, Myers SH, Unfer V, Rasulova I.   +3 more
europepmc   +1 more source

Myo-Inositol for Cutaneous Manifestations of Polycystic Ovary Syndrome: An International Delphi Consensus Recommendation for Dermatology Practice. [PDF]

Cureus
Ganjoo A, Kalra S, Kohli M, Damisetty R, Verma S, Kandhari R, Sharma B, Deka N, Beatrice A, Pradhan AR, Parajuli S, Rahman HA, Shamim SMA, Nair R, Patel P, Kulkarni GR.   +15 more
europepmc   +1 more source